Faculty profile
Caroline Diorio
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Bazedoxifene and Beyond: Identifying This SERM's Targets and Deciphering Its Molecular Mechanisms.
Advances in pharmacological and pharmaceutical sciences · 2026
Mammary Adipocyte Size, Obesity-Related Breast Adipose Tissue Dysfunction, and Breast Cancer: A Systematic Review and Meta-Analysis.
Cancers · 2026 · senior author
Empirically derived dietary patterns and prostate cancer risk: a systematic review and meta-analysis of prospective cohorts.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2026
Latest funding
- $1,262,250
Développement translationnel de l'AIMZ-938 comme thérapie de précision pour les cancers colorectaux réfractaires aux traitements
CIHR · 2026 · Principal investigator
- $271,576
Development of statistical methods for estimating optimal adaptive treatment strategies with survival outcomes
CIHR · 2024 · Principal investigator
- $120,000
Bazédoxifène, médicament contre l'ostéoporose, pour le traitement et la prévention du cancer du sein ?
CIHR · 2024 · Supervisor
106 publications.
Bazedoxifene and Beyond: Identifying This SERM's Targets and Deciphering Its Molecular Mechanisms.
Bherer J, Clemenceau A, Diorio C, Durocher F
Mammary Adipocyte Size, Obesity-Related Breast Adipose Tissue Dysfunction, and Breast Cancer: A Systematic Review and Meta-Analysis.
Badre O, Chang SL, Abdous B, Lemieux J, Durocher F, Tchernof A, Diorio C
Empirically derived dietary patterns and prostate cancer risk: a systematic review and meta-analysis of prospective cohorts.
Ben Souilah F, Tourigny R, Drouin-Chartier JP, Diorio C, Fradet V
Clinical and prognostic significance of parathyroid hormone-related protein in breast cancer: a systematic review and meta-analyses of observational studies in women.
Clemenceau A, Bherer J, Grimshaw A, Durocher F, Diorio C, Wysolmerski JJ
FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938.
Bruxelles Q, Hamel-Côté G, Scott-Boyer MP, Ouellette V, C-Gaudreault R, Durocher F, Diorio C, Droit A, Fortin S
Corrigendum to "First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?" [Cancer Treat. Rev. 135 (2025) 102909].
Nguyen Van Long F, Poirier B, Desbiens C, Perron M, Paquet C, Ouellet C, Diorio C, Lemieux J, Nabi H
Factors influencing traditional adiposity indicators and mammary adipocyte size in women with breast cancer.
Ennour-Idrissi K, Laforest S, Tchernof A, Durocher F, Diorio C
Using Machine Learning to Improve Control for Confounding in the Dynamic Weighted Ordinary Least Squares Estimator of Optimal Adaptive Treatment Strategies.
Trenou KC, Mésidor M, Eslami A, Nabi H, Diorio C, Talbot D
Alcohol consumption and DNA methylation: an epigenome-wide association study within the French E3N cohort.
Dragic D, Artaud F, Karimi M, Truong T, Baglietto L, Deleuze JF, Diorio C, Severi G
Reply to Zeng and Zhou.
Djade CD, Diorio C, Laurin D, Talbot D, Carmichael PH, Dionne CE
Développement translationnel de l'AIMZ-938 comme thérapie de précision pour les cancers colorectaux réfractaires aux traitements
Principal investigators: Fortin, Sébastien; Benoit-Biancamano, Marie-Odile; C.-Gaudreault, René; Diorio, Caroline; Droit, Arnaud; Durocher, Francine; Moreau, Emmanuel; Simard, Chantale
Keywords: Antimitotiques; Cancers Colorectaux; Cancers Colorectaux Métastatiques Et Chimiorésistants; Chimiothérapie Personnalisée; Développement De Médicaments Anticancéreux; Modulateurs D'Ahr; Promédicaments Antimicrotubules
Development of statistical methods for estimating optimal adaptive treatment strategies with survival outcomes
Principal investigators: Talbot, Denis; Diorio, Caroline
Keywords: Biostatistical Methods; Breast Cancer; Causal Inference; Personalized Medicine; Simulation Study
Bazédoxifène, médicament contre l'ostéoporose, pour le traitement et la prévention du cancer du sein ?
Principal investigators: Bherer, Juliette
Keywords: Bazédoxifène; Cancer Du Sein; Interleukine 6; Récepteurs Aux Cannabinoïdes; Serm; Survie; Traitement; Triple-Négatif
TBC1D9: therapeutic target of the aggressiveness of triple negative breast cancer
Principal investigators: Durocher, Francine
Keywords: Biomarker; Breast Cancer; Tbc1 Domain Family Member 9; Tbc1d9; Therapeutic Target; Treatment Option; Triple Negative Breast Cancer
L'AIMZ-938, un nouveau promédicament anticancéreux pour le traitement des cancers du sein humain réfractaires aux traitements actuels et exprimant le cytochrome P450 1A1
Principal investigators: Fortin, Sébastien
Keywords: Antimitotiques; Cancers Du Sein; Cancers Du Sein Chimiorésistants; Cancers Du Sein Triple Négatifs; Chimiothérapie Personnalisée; Développement De Médicaments Anticancéreux; Promédicaments Antimicrotubules
What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer
Principal investigators: Nabi, Hermann
Keywords: Cancer
Management of sleeve gastrectomy failure using single-anastomosis metabolic surgery
Principal investigators: Tchernof, André; Biertho, Laurent
Keywords: Metabolism; Obesity; Surgery
Omega-3 fatty acids in the prevention of breast cancer: role of obesity-related markers in breast tissues
Principal investigators: Diorio, Caroline
Keywords: Adipose Tissue; Aromatase; Breast Cancer; Breast Density; Inflammation; Molecular Markers; Nutrition; Obesity; Omega-3 Fatty Acids; Prevention
Deciphering breast cancer HER2-negativity with regard to HER2-targeted therapy
Principal investigators: Durocher, Francine
Keywords: Breast Cancer Prevention; Breast Cancer Treatment; Breast Tumors; Gene Expression Profile; Her2 Biomarker; Her2 Protein Variants; Her2-Targeted Therapy; Methylation Profile
Effect of environmental contaminants and methylome of breast adipose tissue on aromatase inhibitor efficacy in breast cancer
Principal investigators: Diorio, Caroline
Keywords: Adipose Tissue; Aromatase Inhibitors; Breast Cancer; Environmental Contaminants; Estrogen; Mass Spectometry; Methylation; Treatment
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Chantal Brisson and Xavier Trudel: 44 shared papers
- Francine Durocher and Caroline Diorio: 33 shared papers
- Chantal Brisson and Denis Talbot: 28 shared papers
- Denis Talbot and Xavier Trudel: 25 shared papers
- Vincent Fradet and Paul Toren: 19 shared papers
- Donald Poirier and Sheng-Xiang Lin: 12 shared papers
- Chantal Brisson and Danielle Laurin: 9 shared papers
- Danielle Laurin and Denis Talbot: 9 shared papers
- Danielle Laurin and Xavier Trudel: 9 shared papers
- Caroline Diorio and Denis Talbot: 9 shared papers
- Elie Haddad and Michel Duval: 8 shared papers
- Caroline Diorio and Hermann Nabi: 8 shared papers
- Danielle Laurin and Caroline Diorio: 7 shared papers
- Ali Ahmad and Devendra Amre: 6 shared papers
- Michel Duval and Daniel Sinnett: 5 shared papers
- Devendra Amre and Daniel Sinnett: 4 shared papers
- Caroline Diorio and Vincent Fradet: 4 shared papers
- Anne Gangloff and Jean-Philippe Drouin-Chartier: 4 shared papers
- Elie Haddad and Daniel Sinnett: 3 shared papers
- Chantal Brisson and Caroline Diorio: 3 shared papers
- Alexandre Bureau and Danielle Laurin: 3 shared papers
- Caroline Diorio and Xavier Trudel: 3 shared papers
- Donald Poirier and Francine Durocher: 2 shared papers
- Ali Ahmad and Michel Duval: 2 shared papers
- Ali Ahmad and Daniel Sinnett: 2 shared papers
- Arnaud Droit and Francine Durocher: 2 shared papers
- Arnaud Droit and Caroline Diorio: 2 shared papers
- Arnaud Droit and Jean-Philippe Lambert: 2 shared papers
- Alexandre Bureau and Caroline Diorio: 2 shared papers
- Francine Durocher and Jacques Corbeil: 2 shared papers
- Caroline Diorio and Jacques Corbeil: 2 shared papers
- Caroline Diorio and Anne Gangloff: 2 shared papers
- Jacques Corbeil and Jean-Philippe Drouin-Chartier: 2 shared papers
- Vincent Fradet and Anne Gangloff: 2 shared papers
- Vincent Fradet and Hermann Nabi: 2 shared papers
- Denis Talbot and Hermann Nabi: 2 shared papers
- Elie Haddad and Ali Ahmad: 1 shared paper
- Elie Haddad and Devendra Amre: 1 shared paper
- Elie Haddad and Caroline Diorio: 1 shared paper
- Donald Poirier and Caroline Diorio: 1 shared paper
- Donald Poirier and Jean-Philippe Lambert: 1 shared paper
- Ali Ahmad and Caroline Diorio: 1 shared paper
- Devendra Amre and Caroline Diorio: 1 shared paper
- Dave Richard and Francine Durocher: 1 shared paper
- Dave Richard and Caroline Diorio: 1 shared paper
- Dave Richard and Jacques Corbeil: 1 shared paper
- Laetitia Michou and Francine Durocher: 1 shared paper
- Laetitia Michou and Caroline Diorio: 1 shared paper
- Michel Duval and Caroline Diorio: 1 shared paper
- Arnaud Droit and Alexandre Bureau: 1 shared paper
- Arnaud Droit and Sabine Elowe: 1 shared paper
- Arnaud Droit and Paul Toren: 1 shared paper
- Danielle Laurin and Jean-Philippe Drouin-Chartier: 1 shared paper
- Francine Durocher and Sabine Elowe: 1 shared paper
- Francine Durocher and Jean-Philippe Lambert: 1 shared paper
- Caroline Diorio and Sabine Elowe: 1 shared paper
- Caroline Diorio and Jean-Philippe Lambert: 1 shared paper
- Caroline Diorio and Sheng-Xiang Lin: 1 shared paper
- Caroline Diorio and Daniel Sinnett: 1 shared paper
- Caroline Diorio and Paul Toren: 1 shared paper
- Caroline Diorio and Jean-Philippe Drouin-Chartier: 1 shared paper
- Molecular Medicine
- Pediatrics
- Surgery
- Médecine sociale et préventive
- Social and Preventive Medicine
- Kinesiologie
- Hematology-Oncology
- Other
Co-authors at Université Laval, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Francine Durocher
Molecular Medicine
33 shared papers, latest 2026
Denis Talbot
Faculty
9 shared papers, latest 2025
Hermann Nabi
Faculty
8 shared papers, latest 2026
Danielle Laurin
Faculty
7 shared papers, latest 2025
Vincent Fradet
Surgery
4 shared papers, latest 2026
Xavier Trudel
Médecine sociale et préventive
3 shared papers, latest 2023
Chantal Brisson
Médecine sociale et préventive
3 shared papers, latest 2023
Anne Gangloff
Hematology-Oncology
2 shared papers, latest 2024
Jacques Corbeil
Molecular Medicine
2 shared papers, latest 2020
Arnaud Droit
Microbiologie et immunologie
2 shared papers, latest 2026
Alexandre Bureau
Kinesiologie
2 shared papers, latest 2017
Jean-Philippe Drouin-Chartier
Faculty
1 shared papers, latest 2026
Jean-Philippe Lambert
Molecular Medicine
1 shared papers, latest 2020
Sabine Elowe
Pediatrics
1 shared papers, latest 2022
Sophie Lauzier
Faculty
1 shared papers, latest 2025
Sheng-Xiang Lin
Molecular Medicine
1 shared papers, latest 2015
Daniel Sinnett
Pharmacologie - Physiologie
1 shared papers, latest 2017
Paul Toren
Surgery
1 shared papers, latest 2023
Steve Bilodeau
Centre de recherche en cancérologie
1 shared papers, latest 2025
Sylvie Mader
Chemical Engineering
1 shared papers, latest 2017
Elie Haddad
Pediatrics
1 shared papers, latest 2017
Dave Richard
Faculty
1 shared papers, latest 2019
Laetitia Michou
Médecine
1 shared papers, latest 2020
Michel Duval
Pediatrics
1 shared papers, latest 2017
Éric Dewailly
Sciences animales
1 shared papers, latest 2014
Donald Poirier
Molecular Medicine
1 shared papers, latest 2023
Sylvie Mader
Biochimie et médecine moléculaire
1 shared papers, latest 2017
Ali Ahmad
Faculty
1 shared papers, latest 2017
Devendra Amre
Faculty
1 shared papers, latest 2017
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.